This effort within Penn’s Abramson Cancer Center is led by Dr. Caryn Lerman, the Mary W. Calkins Professor in the Department of Psychiatry. She has been the Director of the Tobacco Use Research Center since 2001, and Deputy Director of the Abramson Cancer Center since 2006. Despite clinical and public health gains in recent decades, cigarette smoking continues to be the greatest preventable cause of cancer morbidity and mortality in the U.S. The Tobacco and Nicotine Research Program led by Dr. Lerman is at the forefront of efforts to “translate discoveries in basic neuroscience, pharmacology, and genetics to improve treatment for tobacco dependence, with emphases on Phase II and Phase III medication development, and research incorporating genetics and neuroimaging”. Dr. Lerman has led a variety of highly prestigious grants awarded to the Penn campus, including two P50s, a U01, and more recently an R35 award for “high impact” NCI investigators. More information about Dr. Lerman’s world-class program in cancer prevention and tobacco and nicotine research can be found here.